Concurrent Trastuzumab with Chemotherapy Optimal Regimen
A study recommends use of trastuzumab concurrently with the taxane portion of chemotherapy for breast cancer patients.
Profile Including Clinical Data and Biologic Markers Predicts DFS
In the BIG 1-98 trial, high-risk patients did best with 5 years of letrozole and low-risk patients did similarly well with any of the trial%u2019s regimens.
Adjusting for Crossover in Analyses of Letrozole vs. Tamoxifen
Letrozole treatment over 5 years was still associated with significantly better overall survival than 5 years with tamoxifen.
2 Clarke Drive Cranbury, NJ 08512